📊 Evidence-Based Reference

model rf d rx d pacemaker leads

Oscor

Summary: The model rf d rx d pacemaker leads by Oscor are FDA-cleared devices used in cardiac pacing. Key evidence includes 7 studies, though none directly related to this device.

FDA Clearance Information

Pathway 510K
Decision Date April 30, 1983
Product Code DTB
Device Class Class 3
Evidence 0 studies

The model rf d rx d pacemaker leads were cleared through the FDA 510(k) pathway on April 30, 1983. Manufactured by Oscor, they are classified as Class III devices.

What It Is

The model rf d rx d pacemaker leads are designed for use in cardiac pacing, facilitating electrical conduction between the pacemaker and the heart muscle. They are intended for patients requiring cardiac rhythm management.

Clinical Applications

These pacemaker leads are commonly used in scenarios where patients have bradycardia or other conditions requiring consistent heart rate regulation. They are integral in maintaining cardiac function in patients with pacing needs.

Evidence Summary

The literature includes 7 studies, though none directly pertain to the model rf d rx d pacemaker leads. The studies range from 2021 to 2025 and cover various medical topics unrelated to this device.

Reported Outcomes

Published studies report no direct outcomes related to the model rf d rx d pacemaker leads. The available evidence does not provide specific efficacy findings for this device.

Safety Profile

Reported complications include no specific safety data for the model rf d rx d pacemaker leads. The evidence provided does not address adverse events or complications for this device.

Evidence Limitations

The current evidence lacks direct studies on the model rf d rx d pacemaker leads, highlighting a gap in device-specific research. Further investigation is needed to assess the efficacy and safety of these leads.

Frequently Asked Questions

What are the clinical indications for model rf d rx d pacemaker leads?

Clinical indications are detailed in the FDA documentation, primarily for cardiac pacing needs.

What outcomes have been reported in clinical studies?

No specific outcomes have been reported for the model rf d rx d pacemaker leads in the provided evidence.

What complications have been reported?

No safety data or complications have been reported for this device in the provided evidence.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.